← FDA Drug Approvals (Drugs@FDA)

LEVONORGESTREL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2018-09-18

Drug application

FDA Application #

ANDA205329

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVONORGESTREL

Generic name

LEVONORGESTREL

Active ingredients

LEVONORGESTREL

Dosage form

TABLET

Route

ORAL

Marketing status

Over-the-counter

Sponsor

XIROMED

Manufacturer

Rapha Pharmaceuticals, Inc.

First approval

2018-09-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown